(02) 9926 4726

News and Event

Prof Dale Bailey Appointed as the New Director of Sydney Vital

Sydney Vital is pleased to announce and welcome Prof Dale Bailey to be our new Centre Director, replacing Prof Alexander Engel. Prof Bailey will be responsible for ensuring the continuation of the many successful programmes already in place at Sydney Vital and leading the plans for the next 5-year programme of Sydney Vital.

Read more

Neuroendocrine Tumours (NETs) for GPs

On Wednesday, 12th June, Sydney Vital co-hosted  Neuroendocrine Tumours (NETs) for GPs – an educational seminar- with Unicorn Foundation, Sydney North Health Network, and IPSEN.

Read more

Sydney/NSW Thyroid Cancer Interest Group – May 2019 Case Discussion Meeting

On 28th May 2019 during the International Thyroid Awareness Week (25th May – 31st May ) and the Thyroid Awareness Month, we were pleased to host the Sydney/NSW Thyroid Cancer Interest Group again with our partner –Eisai Australia.

Read more

COSA elects Dr David Chan as the New chair of the NETs group

Clinical Oncology Society of Australia (COSA) announced on Friday, 10th May that Sydney Vital member, Dr David Chan had been elected as the new chair of the Neuroendocrine Tumours (NETs) group.

Read more

Dr Yaser Gholami Receives Beryl & Jack Jacobs Travel Award

Sydney Vital member Dr Yaser Gholami has received a Bery l& Jack Jacobs Travel Award from the Kolling Institute.

Read more

Research Fellowship Opportunity – Flagship Program 3: Nanotechnology

Sydney Vital Flagship Program 3 is currently looking to hire a Research Fellow.

Read more

Colorectal Preceptorship 2019

On 3rd May 2019, Sydney Vital was pleasured to present the Colorectal Preceptorship 2019 with Merck – an informative and engaging day about the multidisciplinary management of colorectal cancer and the program saw more than 40 trainees from a variety of backgrounds – oncology fellows, registered nurses, pharmacist and other allied health professionals.

Read more

Sydney Vital Contributes In World-First Cancer Trial

A world-first trial of a next-generation cancer treatment which uses a tailored does of radioactive copper to target tumours is underway at Royal North Shore Hospital (RNSH). This new treatment approach had been developed in conjunction with Sydney Vital and Clarity Pharmaceuticals.

Read more

Current Management of Breast Cancer – Breast Cancer Preceptorship 2019

On 8th – 9th March 2019, Sydney Vital co-hosted the Breast Cancer Preceptorship 2019 with Royal North Shore Hospital and Novartis

Read more

Prof Paul Keall Awarded Translational Program Grant from Cancer Institute NSW

Sydney Vital member Prof Paul Keall is awarded a 2019 Translational Program Grant from the Cancer Institute NSW.

Read more